Toronto, Ontario, July 26, 2018 (GLOBE NEWSWIRE) -- Luminar Media Group, Inc., (Luminar, OTCMKTS: LRGR) its wholly owned subsidiary Big Data Media Inc. (BDM) and flu outbreak forecaster Ascel Bio Inc. (Ascel Bio) are pleased to announce the companies have entered into a definitive Mobile Application Development and Content License Agreement.
The mobile application to be developed pursuant to the agreement will produce a flu map, a zika virus map, and other fully-automated forecasts of infectious diseases in the USA. The application covers flu activity by zip code, mosquito diseases, tick diseases, food poisoning, water borne diseases, and common STDs. The application will be capable of generating alerts to aid flu prevention.
This disease forecasting and outbreak warning application addresses the U.S. $120 billion a year costs of infectious disease that impact national security, the general economy, and health care system. During the 2017-2018 flu season the U.S. experienced a particularly virulent flu strain, H3N2 that resulted in Americans being hospitalized for the illness at a rate of 59.9 per 100,000 people.
The Mobile Application will be available on both Apple iOS and Google Android platforms. The application will provide advertising from 3rd parties, sell products through affiliate links, and offer subscriptions or premium content for a fee payable through the application. BDM will own the mobile application, Ascel Bio owns the content and data feeds and both Companies will share equally in the revenue from the Mobile Application.
The application is available at: www.diseasecast.com/map.
Luminar is looking for early stage commercial technologies that can benefit from the team’s entrepreneurial spirit, extensive knowledge and experience in the media, marketing and entertainment industries. We are specifically looking for new tools to communicate with a broad audience that takes advantage of the emerging landscape in how users learn, work and consume media on a variety of digital devices. At Luminar, we embrace the challenge of the constantly evolving business landscape and our determined culture will identify profitable solutions that evolve with the changing business paradigm. The Company was started by entrepreneurs who can identify new tools to communicate with a target audience. At Luminar, we embrace the challenge of the constantly evolving business landscape and our determined culture will develop solutions that evolve with the changing business paradigm.
Luminar President and CEO, Chris Cook is a minority shareholder of Ascel Bio and sits on the Company’s Board of Directors.
About Ascel Bio
Ascel Bio is a disease forecasting and outbreak warning company. Since 2010, Ascel Bio has built a track record for accurate and reliable predictions that inspires action & improves global health. Ascel Bio maintains proprietary APIs to obtain raw data needed to generate forecasts from various health and meteorological data sources. Proprietary models are used to generate forecasts.
This news release contains forward-looking statements about our business, or financial condition and prospects, that reflect our assumptions and beliefs based on information currently available. The Company can give no assurance that the expectations indicated by such forward-looking statements will be realized. There may be other risks and circumstances that we are unable to predict. When used in this news release, words such as "believes," "expects," "intends," "plans," "anticipates," "estimates" and similar expressions are intended to identify forward-looking statements, although there may be certain forward-looking statements not accompanied by such expressions. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including risks discussed in the company's periodic reports that are filed with the Securities and Exchange Commission and available on its website (www.sec.gov). All forward-looking statements attributable to the Company or to persons acting on its behalf are expressly qualified in their entirety by these factors other than as required under the securities laws. The Company does not assume a duty to update these forward-looking statements.
Investors should refer to the risk factors disclosure outlined in our periodic reports filed from time-to-time with the Securities and Exchange Commission.
Luminar Media Group Investor Relations